Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
NRC Health Common Stock
NRC
$431M
| $3.26M | ﹤0.01% |
226,416
+5,645
| +3% | +$79.8K |
|
|
OIG
3202
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $3.25M | ﹤0.01% |
13,876
+1,189
| +9% | +$295K |
|
|
AOI
3203
DELISTED
Alliance One International
AOI
| $3.24M | ﹤0.01% |
294,245
-61,269
| -17% | -$688K |
|
3204
QuickLogic
QUIK
$246M
| $3.2M | ﹤0.01% |
118,479
+8,297
| +8% | +$268K |
|
3205
Akebia Therapeutics
AKBA
$264M
| $3.2M | ﹤0.01% |
287,842
+56,517
| +24% | +$602K |
|
3206
Cineverse
CNVS
$62.3M
| $3.2M | ﹤0.01% |
9,863
+376
| +4% | +$117K |
|
|
NPTN
3207
DELISTED
NEOPHOTONICS CORP
NPTN
| $3.19M | ﹤0.01% |
472,815
+50,289
| +12% | +$202K |
|
3208
Perspective Therapeutics
CATX
$339M
| $3.19M | ﹤0.01% |
202,894
-2,420
| -1% | -$35.9K |
|
3209
UFP Technologies
UFPT
$2.41B
| $3.17M | ﹤0.01% |
139,152
+3,006
| +2% | +$68.1K |
|
|
OLBK
3210
DELISTED
Old Line Bancshares, Inc.
OLBK
| $3.17M | ﹤0.01% |
200,491
+3,168
| +2% | +$47.5K |
|
|
GUID
3211
DELISTED
Guidance Software, Inc.
GUID
| $3.16M | ﹤0.01% |
584,113
+2,808
| +0.5% | +$17.2K |
|
3212
SFL Corp
SFL
$1.61B
| $3.16M | ﹤0.01% |
213,328
+17,830
| +9% | +$265K |
|
3213
Tenax Therapeutics
TENX
$498M
| $3.15M | ﹤0.01% |
30
| – | – |
|
|
ISRL
3214
DELISTED
Isramco Inc
ISRL
| $3.14M | ﹤0.01% |
24,972
+94
| +0.4% | +$12.2K |
|
|
GNCA
3215
DELISTED
Genocea Biosciences, Inc.
GNCA
| $3.14M | ﹤0.01% |
33,102
+18,671
| +129% | +$1.32M |
|
3216
RAVE Restaurant Group
RAVE
$44.5M
| $3.14M | ﹤0.01% |
224,870
+31,511
| +16% | +$382K |
|
|
ALSK
3217
DELISTED
Alaska Communications Systems
ALSK
| $3.13M | ﹤0.01% |
1,861,277
+102,520
| +6% | +$174K |
|
3218
Blue Bird Corp
BLBD
$2.09B
| $3.12M | ﹤0.01% |
+304,452
| New | +$2.95M |
|
3219
INNOVATE Corp
VATE
$101M
| $3.1M | ﹤0.01% |
+28,320
| New | +$2.4M |
|
|
RXDX
3220
DELISTED
Ignyta, Inc.
RXDX
| $3.09M | ﹤0.01% |
310,625
+8,710
| +3% | +$65.2K |
|
3221
Denison Mines
DNN
$2.83B
| $3.08M | ﹤0.01% |
+3,904,134
| New | +$3.43M |
|
|
BPTH
3222
DELISTED
Bio-Path Holdings Inc
BPTH
| $3.07M | ﹤0.01% |
427
+6
| +1% | +$50.4K |
|
3223
Pixelworks
PXLW
$40.6M
| $3.06M | ﹤0.01% |
50,849
+3,371
| +7% | +$206K |
|
3224
RCI Hospitality Holdings
RICK
$201M
| $3.05M | ﹤0.01% |
292,836
+6,301
| +2% | +$64.7K |
|
|
NWHM
3225
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $3.05M | ﹤0.01% |
191,049
+2,754
| +1% | +$39.5K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.